Evotec's US Unit, Alpine Immune Sciences Expand Deal To Commercially Develop ALPN-303

Evotec AG (EVO), a German life science company, Wednesday said its US-based subsidiary, Just - Evotec Biologics, Inc., expanded a multi-year partnership with Alpine Immune Sciences, Inc. (ALPN).

The deal is for the development of a commercial process for ALPN-303, an engineered TACI domain with significantly improved potency against the B cell cytokines BAFF and APRIL, to treat systemic lupus erythematosus and other B cell-mediated inflammatory and autoimmune diseases.

The company said the latest contract is a continuation of their first-in-human program initiated in 2020. In the program, Just - Evotec Biologics delivered drug substance materials using their J.DESIGN continuous manufacturing platform for Alpine's ongoing Phase I study and anticipated Phase II studies of ALPN-303.

Under the expanded contract, Just - Evotec Biologics will leverage its data-driven technology platform to develop a commercial manufacturing process for ALPN-303.

The programme includes upstream and downstream process, analytical method, and formulation development with a view to support commercial manufacturing of ALPN303.

Commercial process development activities will be performed at Just - Evotec Biologics' biomanufacturing facility located in Redmond, Washington.

For More Such Health News, visit rttnews.com

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Elon Musk's brain implant firm Neuralink said it has received approval from the U.S. Food and Drug Administration to conduct first-in-human clinical trials. In a tweet, Neuralink said, "We are excited to share that we have received the FDA's approval to launch our first-in-human clinical study! T.W. Garner Food Co. is recalling 50,688 bottles of 12 oz. Texas Pete Buffalo Wing Sauce citing undeclared soy, the U.S. Food and Drug Administration said. The agency noted that some of the bottles may contain Texas Pete Extra Mild Wing Sauce which contains soy. The recall involves Texas Pete Buffalo Wing Sauce with best used by 120623T 065239 UPC 0 75500 10011 6. The U.S. Food and Drug Administration approved Pfizer Inc's COVID-19 oral antiviral pill Paxlovid for the treatment of mild-to-moderate COVID-19 in adults. Paxlovid is the first oral treatment, and the fourth drug, approved by the agency to treat COVID-19 in adults. Paxlovid (nirmatrelvir tablets and ritonavir tablets, co-packaged for oral use) has been approved to treat adults who are at high...
Follow RTT